The DOI matches its Crossref record; 45 of the 49 references it cites were found in a registry or an index.
Effects of Aromatase Inhibition on Bone Mineral Density and Bone Turnover in Older Men with Low Testosterone Levels
Open accessAbstract
Context: Aging is associated with declining gonadal steroid production, low bone mineral density (BMD), and fragility fractures. The efficacy and safety of testosterone replacement in older men remains uncertain. Objective: The objective of the study was to assess the effects of aromatase inhibition on BMD in older men with low testosterone levels. Design and Setting: This was a 1-yr, double-blind, randomized, placebo-controlled trial that was conducted at a tertiary care academic center in Boston, MA. Participants: Participants included 69 men aged 60+ yr with borderline or low testosterone levels and hypogonadal symptoms. Intervention: Intervention included 1 mg anastrozole daily or placebo. Main Outcome Measures: Changes in gonadal steroid hormone levels, BMD, and bone turnover markers were measured. Results: Mean serum testosterone increased from 319 ± 93 ng/dl at baseline to 524±139 ng/dl at month 3 (P < 0.0001) and declined slightly to 474 ± 145 ng/dl by 1 yr. Estradiol levels decreased from 15 ± 4 pg/ml at baseline to 12 ± 4 pg/ml at month 3 and then remained stable (P < 0.0001). Posterior-anterior (PA) spine BMD decreased in the anastrozole group as compared with placebo (P = 0.0014). In the anastrozole group, PA spine BMD decreased from 1.121 ± 0.141 g/cm2 to 1.102 ± 0.138 g/cm2, whereas in the placebo group, PA spine BMD increased from 1.180 ± 0.145 g/cm2 to 1.189 ± 0.146 g/cm2. Qualitatively similar, but not statistically significant, changes occurred at the other sites. Bone turnover markers were not affected by anastrozole therapy. Conclusions: In older men, aromatase inhibition increases testosterone levels, decreases estradiol levels, and appears to decrease BMD. Aromatase inhibition does not improve skeletal health in aging men with low or low normal testosterone levels.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As long-term AI use has been associated with decreases in bone mineral density due to suppression of E2, the AUA recommends against the use of AI for prolonged periods (1,72).”
From Non-testosterone management of male hypogonadism: an examination of the existing literature (2020) · cites this paper as [72]
In the citing paper
“Tamoxifen was much more effective, however, in the prevention of gynecomastia in these men [69,70].”
From Aromatase inhibitors in men: effects and therapeutic options (2011) · cites this paper as [69]
In the citing paper
“A dose of 1 mg daily appeared to be mildly effective against the appearance of gynecomastia.”
From Aromatase inhibitors in men: effects and therapeutic options (2011) · cites this paper as [69]
In the citing paper
“while Burnett-Bowie’s group identified significant reductions in bone mineral density with therapy.”
From Challenges in Testosterone Measurement, Data Interpretation, and Methodological Appraisal of Interventional Trials (2016) · cites this paper as [126]
In the citing paper
“Results from the Leder trial reported no change in markers of bone turnover, despite greater mean reductions in estradiol”
From Challenges in Testosterone Measurement, Data Interpretation, and Methodological Appraisal of Interventional Trials (2016) · cites this paper as [126]
In the citing paper
“Although one publication of men undergoing anastrozole therapy over a 3-month period demonstrated no significant change in markers of bone resorption, a subsequent 12-month study demonstrated direct radiologic evidence of bone mineral density loss despite unchanged markers of bone resorption.125, 126”
From Challenges in Testosterone Measurement, Data Interpretation, and Methodological Appraisal of Interventional Trials (2016) · cites this paper as [126]
In the citing paper
“This is evidenced by the significant variation on bone mineral density among the reported therapies.126, 127, 135”
From Challenges in Testosterone Measurement, Data Interpretation, and Methodological Appraisal of Interventional Trials (2016) · cites this paper as [126]
In the citing paper
“Moreover, as discussed below, AIs reduce bone density.”
From Hypogonadism and male obesity: Focus on unresolved questions (2018) · cites this paper as [110]
In the citing paper
“Of concern, BMD at the spine decreased significantly after 12 months of anastrozole, presumably because of the decrease in circulating oestradiol.110”
From Hypogonadism and male obesity: Focus on unresolved questions (2018) · cites this paper as [110]
Citations
Cites
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Estrogen Resistance Caused by a Mutation in the Estrogen-Receptor Gene in a Man
Smith, E. P., Boyd, J., Frank, G. R., Takahashi, H., Cohen, R. M., Specker, B., Williams, T. C., Lubahn, D. B., & Korach, K. S. (1994) · New England Journal of Medicine · doi:10.1056/nejm199410203311604 · Cited by 2,471
Shumaker, S. A., Legault, C., Rapp, S. R., Thal, L., Wallace, R. B., Ockene, J. K., Hendrix, S. L., Jones III, B. N., Assaf, A. R., Jackson, R. D., et al. (2003) · JAMA · doi:10.1001/jama.289.20.2651 · Cited by 2,178
Bone Quality — The Material and Structural Basis of Bone Strength and Fragility
Seeman, E., & Delmas, P. D. (2006) · New England Journal of Medicine · doi:10.1056/nejmra053077 · Cited by 2,157
The Decline of Androgen Levels in Elderly Men and Its Clinical and Therapeutic Implications
Kaufman, J. M., & Vermeulen, A. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0013 · Cited by 1,079
Bhasin, S., Cunningham, G. R., Hayes, F. J., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., & Montori, V. M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2847 · Cited by 965
The Effects of Parathyroid Hormone, Alendronate, or Both in Men with Osteoporosis
Finkelstein, J. S., Hayes, A.-M., Hunzelman, J. L., Wyland, J. J., Lee, H., & Neer, R. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035725 · Cited by 823
Self-citationEffects of testosterone supplementation in the aging male
Tenover, J. S. (1992) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.75.4.1092 · Cited by 768
Falahati-Nini, A., Riggs, B. L., Atkinson, E. J., O’Fallon, W. M., Eastell, R., & Khosla, S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10942 · Cited by 757
Effects of testosterone supplementation in the aging male.
Tenover, J. S. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.75.4.1400877 · Cited by 702
Flagged first, then by citations
4 of the 49 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–146 of 146
Rethinking Osteoporosis Drugs: Can We Simultaneously Address Sarcopenia?
Gavrilov, Z., & Lojk, J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146924 · Cited by 7
Testosterone and male rejuvenation
Helo, S., Thomas, P., & Tadros, N. N. (2019) · Panminerva Medica · doi:10.23736/s0031-0808.18.03513-9 · Cited by 5
Sperm Concentration and Total Sperm Count
Ambar, R. F., Maziotis, E., & Simopoulou, M. (2024) · Springer eBooks · doi:10.1007/978-3-031-55337-0_4 · Cited by 5
Testosterone: More Is Not Always Better
Khosla, S. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2134 · Cited by 5
Treatment of Estrogen Levels in the Management of Hypogonadism: An Anonymous Survey of ISSM Members
Butaney, M., Thirumavalavan, N., Balasubramanian, A., McBride, J. A., Gondokusumo, J. C., Pastuszak, A. W., & Lipshultz, L. I. (2020) · Urology · doi:10.1016/j.urology.2020.01.032 · Cited by 5
Diagnosis and treatment of hypogonadism in men seeking to preserve fertility – what are the options?
Lockie, A. W. C., Grice, P., Mathur, R., Pearce, I., & Modgil, V. (2024) · International Journal of Impotence Research · doi:10.1038/s41443-024-00897-4 · Cited by 4
Tree nut consumption is associated with a lower risk of hyperestrogenism in men
Wang, Y., & Fang, Y. (2021) · Nutrition Research · doi:10.1016/j.nutres.2021.12.001 · Cited by 4
Borgert, B. J., Bacchus, M. W., Hernandez, A. D., Potts, S. N., & Campbell, K. J. (2023) · Sexual Medicine · doi:10.1093/sexmed/qfad004 · Cited by 4
Clinical Urologic Endocrinology
Fode, M., Quallich, S. A., Reisman, Y., Sønksen, J. O. R., & Ohl, D. A. (2012) · Springer eBooks · doi:10.1007/978-1-4471-4405-2 · Cited by 4
Testosterone Therapy and Male Fertility
Brannigan, R. E. (2021) · Springer eBooks · doi:10.1007/978-3-030-77111-9_6 · Cited by 3
Čeponis, J., Wang, C., Swerdloff, R. S., & Liu, P. Y. (2017) · Endocrinology · doi:10.1007/978-3-319-29456-8_11-1 · Cited by 3
Kaufman, J., T'Sjoen, G. G., & Vermeulen, A. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139003353.017 · Cited by 3
Čeponis, J., Wang, C., Swerdloff, R. S., & Liu, P. Y. (2017) · Endocrinology · doi:10.1007/978-3-319-44441-3_11 · Cited by 3
Rubenstein, E. P. (2026) · International Journal on Science and Technology · doi:10.71097/ijsat.v17.i2.11342 · Cited by 2
Other Hormonal Therapies and Men's Health
Hawksworth, D. J., & Burnett, A. L. “. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816665-9.00013-5 · Cited by 2
Androgen Replacement Therapy in Hypogonadal Men
Čeponis, J., Swerdloff, R. S., & Wang, C. (2017) · Springer eBooks · doi:10.1007/978-3-319-53298-1_18 · Cited by 2
Samson, S. L. (2026) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2026.102100 · Cited by 1
Čeponis, J., Wang, C., Swerdloff, R., & Liu, P. Y. (2026) · Endocrinology · doi:10.1007/978-3-319-29456-8_11-2
Traitement androgénique des hypoandrismes masculins
Kuhn, J., & Prévost, G. (2013) · La Presse Médicale · doi:10.1016/j.lpm.2013.06.021 · Cited by 1
Testosterone Booster Recommendation Report
LeBaron, T. W. (2011) · Cited by 1
Specific Endocrinopathies and Male Infertility
Harisaran, V., Cone, E. B., & Hwang, K. (2012) · Springer eBooks · doi:10.1007/978-1-4471-4405-2_8 · Cited by 1
The Effects of Androgens on Bone Metabolism: Clinical Aspects
Sfeir, J. G., & Drake, M. T. (2020) · Contemporary Endocrinology · doi:10.1007/978-3-319-69287-6_13 · Cited by 1
Baik, S. H., Baye, F. M., Fung, K. W., Xian, H., & McDonald, C. J. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf504 · Cited by 1
Uso de inibidores da aromatase para melhora estatural em meninos: uma revisão literária
Cruz, M. O., & Saab, A. R. M. (2023) · Research Society and Development · doi:10.33448/rsd-v12i2.40181 · Cited by 1
Medical Management of Male Infertility
Kovac, J. R. (2023) · Cambridge University Press eBooks · doi:10.1017/9781009197533.014 · Cited by 1
Buisson, J. (2010) · Les cahiers de l année gérontologique · doi:10.1007/s12612-010-0062-4
Alternate Therapies for Testosterone Replacement
Şerefoğlu, E. C., Gökçe, A., Hellstrom, W. J. G., & Guay, A. T. (2012) · Humana Press eBooks · doi:10.1007/978-1-62703-179-0_11
Meikle, A. W. (2010) · Yearbook of Endocrinology · doi:10.1016/s0084-3741(10)79444-0
Osteoporosis: May Doping Cause It?
Menafra, D., Minetto, M. A., Salzano, C., de Angelis, C., & Pivonello, R. (2020) · Trends in andrology and sexual medicine · doi:10.1007/978-3-319-96376-1_15
Rastrelli, G., Maggi, M., & Corona, G. (2022) · doi:10.1093/med/9780198870197.003.0387
(2010) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e328339f31e
Androgens, Androgen Receptor, and Bone
Colucci, S. C., & Brunetti, G. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11229-2
Zajac, J. D., Seeman, E., Russell, N., Ramchand, S. K., Bretherton, I., Grossmann, M., & Davey, R. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11263-2
Maintenance of Fertility in the Male Patient with Hypogonadism
Lo, E. M., & Khera, M. (2022) · Springer eBooks · doi:10.1007/978-3-030-99918-6_6
Male Hypogonadism and Fertility
Khalafalla, K. M., de Souza, R. P., Ohlander, S. J., & NIEDERBERGER, C. S. (2023) · Springer eBooks · doi:10.1007/978-3-031-31501-5_11
Effects of Exogeneous Androgenic Agents on Male Reproduction
Cahill, E. M., Bryson, C. F., & Honig, S. C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-21477-6.00097-3
Hypogonadism in Infertile Men: A Clinical Minefield
Rambhatla, A., & Atmoko, W. (2024) · Springer eBooks · doi:10.1007/978-3-031-62648-7_14
Männlicher Hypogonadismus und Fruchtbarkeit
Khalafalla, K. M., de Souza, R. P., Ohlander, S. J., & NIEDERBERGER, C. S. (2024) · Springer eBooks · doi:10.1007/978-3-031-65245-5_11
Testosterone Replacement Therapy
Amory, J. K., & Amory, T. G. (2025) · Springer eBooks · doi:10.1007/978-3-031-96376-6_18
Vincentis, S. D., David, K., Antonio, L., & Rochira, V. (2025) · Springer eBooks · doi:10.1007/978-3-031-96376-6_22
Management of Secondary Hypogonadism in Men with NOA
Ho, C. C. K., Le, S. T., & Gül, M. (2026) · Springer eBooks · doi:10.1007/978-3-031-99431-9_7
A critical analysis of the quality of testosterone therapy randomized controlled trials
Furtado, T., Novaes, L. F., Flores, J. M., & Mulhall, J. P. (2026) · Sexual Medicine Reviews · doi:10.1093/sxmrev/qeag064
Bandura, A., Ďurina, P., Cambal, E., & Kečkéš, Š. (2026) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2026.107121
Robarge, J. (2014) · IUScholarWorks (Indiana University) · doi:10.7912/c2/304
Metadata
- Authors
- Burnett-Bowie, S.-A. M., McKay, E. A., Lee, H., & Leder, B. Z.
- Affiliations
- Endocrine Unit, Massachusetts General Hospital, Boston, Massachusetts 02114
- Massachusetts General Hospital (US)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2009-12-01
- Volume
- 94
- Issue
- 12
- Pages
- 4785-4792
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC2795655
- OpenAlex
- W2062086785
- Cited by
- 146
- References
- 49
- Citations by year
- 2026: 6 · 2025: 6 · 2024: 8 · 2023: 7 · 2022: 7 · 2021: 7 · 2020: 14 · 2019: 9 · 2018: 4 · 2017: 8 · 2016: 16 · 2015: 8 · 2014: 12 · 2013: 8 · 2012: 11
- FWCI
- 6.31
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Massachusetts General Hospital
- National Institute on Aging (R01AG025099, R01-AG-025099-03)
- National Center for Research Resources (K23-RR-161310, M01RR001066, M01-RR01066)
- NIH Clinical Center
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Keywords
- aromatase inhibition, anastrozole, bone mineral density, bone turnover markers, androgen deficiency, hypogonadism, older men, aging, testosterone replacement therapy, estradiol, sex steroids, fragility fractures
- MeSH terms
- Anastrozole, Aged, Aging, Bone and Bones, Double-Blind Method, Enzyme-Linked Immunosorbent Assay, Hormones, Humans, Male, Middle Aged, Nitriles, Patient Compliance, Steroids, Testis, Testosterone, Triazoles, Biomarkers, Bone Density, Endpoint Determination, Aromatase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
